Invectys
PrivateLast Round
Early Funding
Oct 10, 2024
Total Funding Raised
$40.1M
Company Overview
Invectys operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was an Early Funding round in October 2024.
Invectys is a biopharmaceutical company that develops innovative immunotherapy approaches to treat cancer by targeting HLA-G and telomerase antigens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Invectys Comparables
Compare Invectys with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AffyImmune Therapeutics | 83% | |
| NKILT Therapeutics | 80% | |
| Tizona Therapeutics | 79% |
For institutional investors. Book with your work email.
Invectys Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 10, 2024 | ||||
| Grant | May 20, 2020 | ||||
| Series A | Oct 29, 2018 | ||||
| Early Funding | Jul 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Invectys Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cancer Prevention and Research Institute of Texas | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Monthly visitors increased 202% MoM, reaching 1.1K.
- Mar 1, 2026
Monthly visitors increased 68% MoM.
For institutional investors. Book with your work email.
Invectys Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Invectys's valuation, stock price, and market status.
Is Invectys a public or private company?
Invectys is a private company.
What is the current stock price of Invectys?
Invectys is a private company, so its shares have no public market price. Caplight tracks Invectys's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Invectys worth (valuation)?
Valuation information for Invectys is not publicly available.
Can I buy Invectys stock?
Invectys shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Invectys's last funding round?
Invectys's most recent funding round was Early Funding on October 10, 2024.
Who are the main investors in Invectys?
Key investors in Invectys include Cancer Prevention and Research Institute of Texas.
Will Invectys IPO soon?
No public IPO plans have been announced for Invectys.
How can I track Invectys secondary market activity?
Caplight tracks bids, offers, and trades in Invectys's shares on secondary markets.